{"id":"W3097472105","doi":"10.1182/blood-2020-136422","title":"SWOG S1826: A Phase III, Randomized Study of Nivolumab Plus AVD or Brentuximab Vedotin Plus AVD in Patients with Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University Health Network; McGill University","funders":"","keywords":"Brentuximab vedotin; Medicine; ABVD; Dacarbazine; Internal medicine; Chemotherapy regimen; Oncology; Regimen; Procarbazine; Vincristine; Nivolumab; Surgery; Chemotherapy; Cyclophosphamide; Lymphoma; Cancer; Hodgkin lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001155172,0.001538874,0.001963545,0.0003802374,0.0003306457,0.001119478,0.000797927,0.001060316,0.004841392],"category_scores_gemma":[0.0006598161,0.0006842506,0.001229343,0.0003459123,0.0008990973,0.0008669065,0.0003139455,0.002661838,0.000898087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007404333,"about_ca_system_score_gemma":0.001051985,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001037028,"about_ca_topic_score_gemma":0.003342675,"domain_scores_codex":[0.9997439,0.0001305711,0.00001229254,0.0000405292,0.00001890879,0.00005376184],"domain_scores_gemma":[0.9995933,0.00005996252,0.00007362662,0.00001921237,0.000023652,0.0002303443],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9004043,0.02372816,0.002731614,0.001366065,0.001582954,0.0001156255,0.0001534964,0.001183468,0.01041925,0.0002848323,0.003730849,0.05429918],"study_design_scores_gemma":[0.8552433,0.1364518,0.003929941,0.00004849094,0.0004521156,0.0001022081,0.00005507623,0.0006491027,0.0006517951,0.0001800104,0.002212623,0.00002350721],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903189,0.004093391,0.0003901963,0.0005977326,0.0003849533,0.001776182,0.0008863882,0.0001282482,0.001424055],"genre_scores_gemma":[0.9836546,0.003942188,0.001329227,0.001713685,0.0002837509,0.002550415,0.001635993,0.00003769789,0.00485248],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004841392,"threshold_uncertainty_score":0.01619607,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01465063450210115,"score_gpt":0.2650438985331142,"score_spread":0.2503932640310131,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}